OBSTRÜKTİF UYKU APNE SENDROMU VE PSİKİYATRİ

Obstrüktif Uyku Apne Sendromu (OUAS) çeşitli patofizyolojik değişikliklere yol açarak nörolojikve psikiyatrik sistemleri etkiler. Tekrarlayan apne atakları uyku bütünlüğünü bozarak uyku kalitesini olumsuz etkiler. Bu yüzden OUAS olan hastalarda nöropsikiyatrik açıdan çok sayıda problemgelişebilir (1). Birçok çalışmada OUAS ile depresyon ve yaşam kalitesinde bozulma olduğu bildirilmektedir (2-3).Bu derlemede psikiyatrik açıdan OUAS hastalarına yaklaşım, bilişsel işlevler,yaşam kalitesi, eş tanılar ve tedavide dikkat edilecek hususlar ele alınmıştır.

Obstructive Sleep Apne Syndrome And Psychiatry

Obstructive Sleep Apnea Syndrome (OSAS) affects neurological and psychiatric systems by causing various pathophysiological changes. Recurrent episodes of apnea disrupt sleep quality by distrupting sleep architecture. Therefore, OSAS patients may have a number of neuropsychiatric problems (1). Many studies have reported that depression and impaired quality of life are seen with OSAS (2,3). In this review, psychiatric approaches for cognitive functions, quality of life, similar diagnosis, and considerations for treatment for OSAS patients are discussed.

PDF

___

1. Guilleminault C, Stoohs R, Clerk A, et al. From obstructive sleep apnea syndrome to upper airway resistance syndrome, consistency of daytime sleepiness. Sleep, 1992; 15: 13-6.
2. Demir B, Mercan S. Uyku Bozuklukları RCHP 1: 1 Ocak 2007: 7-20.
3. Silverberg DS, Laina A, Oksenberg A. Treating obstructive sleep apnea improves essential hypertension and quality of life. Am Fam Physician 2002; 2: 229-36.
4. Ertuğrul A, Rezaki M. Uykunun nörobiyolojisi ve bellek üzerine etkileri. Türk Psikiyatri Dergisi 2004; 15: 300-8.
5. American Academy of Sleep Medicine. ICSD-2: The International Classification of Sleep Disorders. Diagnostic and Coding Manual, Ed.2, Westchester, Illinois: AASM,2005.
6. Köktürk O, Çiftçi TU. Obstrüktif Uyku Apne Sendromu ilişkili hastalıklar ve ayırıcı tanı. Tüberküloz ve Toraks Dergisi 2002; 50(1): 104-18.
7. Köktürk O. Obstrüktif Uyku Apne Sendromu klinik özellikler. Tüberküloz ve Toraks Dergisi 1999; 47.(1): 117-26.
8. Krieger J. Clinical presentations of sleep apnoea. European Respiratory Monograph 1998; 10: 75-105.
9. Bardwell WA, Berry CC, Israel SA, et al. Psychological correlates sleep apne. Journal of Psychosomatic Research 1999; 47: 583-96.
10. Pillar G, Lavie P. Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest 1998; 114: 697-703.
11. Quereshi A,Ballard RD,Nelson HS. Obstructive sleep apnea Journal of Allergy and Clinical Immunology 2003; 112: 643-651.
12. Sharafkhaneh A, Richardson P, Hirshkowitz M. Sleep apnea in a high risk population: a study of veterans health administration beneficiaries. Sleep Med 2004; 5: 345-550.
13. Fidan F, Ünlü M, Sezer M ,et al. Compliance to CPAP treatment and effects of treatment on anxiety and depression in patients with obstructive sleep apnea syndrome 2007; 55(3):271-277.
14. Çelik M, Sarıkaya Y, Acar M, et al. Obstrüktif Uyku Apne Sendromu Olan Hastalarda Sürekli Hava yolu Basıncı Tedavisinin Depresyon,Kaygı ve algılanan Stres düzeylerine etkisi. Türk Psikiyatri Dergisi 2016;27
15. Edwards C, Mukherjee S, Simpson L, et al. Depressive symptoms before and after treatment of obstructive sleep apnea in men and women. J Clin Sleep Med 2015;11: 1029-1038.
16. Henke KG, Grady JJ, Kuna ST. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apneahypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 2001; 163:911?917.
17. Sforza E, De Saint Hilaire Z, Pelissolo A, et al. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med 2002; 3: 139–45.
18. Doherty LS, Kiely JL, Lawless G, et al. Impact of nasal continuous positive airway pressure therapy on the quality of life of bed partners of patients with obstructive sleepapnea syndrome. Chest 2003; 124: 2209–14.
19. Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: Towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res 2002; 11: 1-16.
20. Aloia MS, Arnedt JT, Davis JD, et al. Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: A critical review. J. In Neuropsychological Society 2004;10: 772-85.
21. Borak J, Cieslicki, J, Szelenberger W, et al. Psychopathological characteristics of the consequences of obstructive sleep apnea prior to and three months after CPAP. Psychiatria Polska 1994; 28: 33-44.
22. Findley LJ, Barth JT, Powers DC, et al. Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia. Chest 1986; 90: 686-90.
23. Fuhrer MJ. Subjective well-being: Implications for medical rehabilitation outcomes and models of disablement. Am J Phys Med Rehabil 1994;73: 358-64.
24. The WHOQOL Group. Development of the World Health Organization WHOQOL-Brief quality of life assessment. Psychol Med 1998; 28: 551-9.
25. Dijkers MP. Individualization in quality of life measurement: Instruments and approaches. Arch Phys Med Rehabil 2003;84(4):3-14.
26. Atagöz K. KOAH olan hastaların yaşam kalitelerinin incelenmesi (tez). İzmir: D.Ü Sağlık Bilimleri Enstitüsü;1998.
27. Aloia M, Arnedt JT, Smith L, et al. Examining the construct of depression in obstructive sleep apnea syndrome. Sleep Med 2005; 6: 115-121.
28. Sharafkhaneh A, Giray N, Richardson P, et al. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005; 28(11):1405-11.
29. Köktürk O. Obstrüktif Uyku Apne Sendromu sonuçları.Uyku bozuklukları dizisi. Tuberk Toraks 2000;48(3):273-89.
30. Aldrich MS. Obstructive sleep apnea syndrome. In: Aldrich MS (Ed). Sleep medicine. New York: Oxford University Press; 1999. p.202-36.
31. Parish JM, Lyng PJ. Quality of life in bed partners with obstructive sleep apne or hypopnea after treatment with continuous positive airway pressure. Chest 2003;124:942-7.
32. Doherty LS, Kiely JL, Lawless G, et al. Impact of nasal continuous positive airway pressure therapy on the quality of life of bed partners of patients with obstructive sleep apnea syndrome. Chest 2003;124(6):2209-14.
33. Köktürk O. Obstrüktif uyku apne sendromu epidemiyolojisi. Tüberküloz ve Toraks Dergisi 1998; 46: 193-201.
34. Montserrat JM, Ballester E, Hernandez L. Overview of management options for snoring and sleep apnea. Eur Respir Mon (Respiratory Disorders During Sleep) 1998; 3: 144-78.
35. Sanders MH. Medical therapy for obstructive sleep apnea- hypopnea syndrome. In: Kryger MH, Roth T, Dement WC (eds). Principles and Practice of Sleep Medicine. Philadelphia:WB Saunders Company 2000: 879-93.
36. Whyte KF, Gould GA, Airlie MA, et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988; 11: 463-8.
37. Hudgel DW. Treatment of obstructive sleep apnea. Chest 1996; 109: 1347-58.